Deborah Templer
Deborah Templer
(416) 862-5785
(416) 868-0673
66 Wellington St W, Suite 5300, TD Bank Twr, Toronto, ON
Year called to bar: 2006 (ON)
Deborah Templer is one of Canada’s leading commercial and product liability litigators, with a national practice defending clients in multi-jurisdictional commercial, product liability, and mass tort actions. Her recent significant mandates include acting for Philip Morris International, Rothmans Benson & Hedges, Endo Pharmaceuticals, Paladin Labs, JUUL Labs, and Behr Process Corporation in defence of product liability actions, including multi-billion dollar class actions and health-care cost recovery litigation in the long-running Canadian tobacco and opioid litigation. She has also acted for Bell Canada for much of her career in respect of commercial disputes, and is frequently retained to represent clients in respect of shareholder and oppression claims. Deborah has appeared in courts across Canada, including in Courts of Appeal and the Supreme Court of Canada, and in the Federal Court. She is a regular instructor on trial advocacy for The Advocates’ Society, Osgoode Hall Law School’s Intensive Trial Advocacy Workshop, Ryerson University’s LPP Trial Advocacy training program, and is a sessional instructor for the University of Windsor Faculty of Law. Deborah is a Director of Pro Bono Ontario and a member of The Advocates’ Society’s 10+ Standing Committee.
Deborah Templer is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Canadian Legal Lexpert Directory
Repeatedly Recommended
Deborah Templer is also listed in the following publication(s)
Read more about Deborah Templer in ...
On May 20, 2015, BCE Inc. (BCE) and Rogers Communications Inc. (Rogers) completed their acquisition of GLENTEL Inc. (GLENTEL), a Canadian-based multi-carrier mobile products distributor.
Petroamerica Oil Corp. and Suroco Energy Inc. fended off a hostile bid by Vetra Holding S.a.r.l. and Vetra Acquisition Ltd. and completed a plan of arrangement pursuant to which Petroamerica acquired all the issued and outstanding shares of Suroco for an approximate total value of $108.6 million.